Lemonade (NYSE:LMND – Get Free Report)‘s stock had its “equal weight” rating reissued by equities research analysts at Morgan Stanley in a research report issued on Wednesday, MarketBeat.com reports. They currently have a $75.00 target price on the stock. Morgan Stanley’s price objective indicates a potential downside of 3.49% from the stock’s current price. LMND […]

Vale (NYSE:VALE – Get Free Report)‘s stock had its “equal weight” rating reaffirmed by stock analysts at Morgan Stanley in a research note issued on Wednesday, MarketBeat.com reports. They currently have a $16.50 price objective on the basic materials company’s stock, down from their previous price objective of $19.50. Morgan Stanley’s price target suggests a […]

Compass Pathways (NASDAQ:CMPS – Get Free Report)‘s stock had its “overweight” rating restated by investment analysts at Morgan Stanley in a research report issued on Tuesday,Benzinga reports. They presently have a $17.00 target price on the stock. Morgan Stanley’s target price would indicate a potential upside of 31.94% from the stock’s current price. Several other […]

Compass Pathways (NASDAQ:CMPS – Get Free Report)‘s stock had its “buy” rating reiterated by analysts at HC Wainwright in a research report issued to clients and investors on Wednesday,Benzinga reports. They currently have a $70.00 price target on the stock. HC Wainwright’s price objective would indicate a potential upside of 432.81% from the company’s current […]

Universal Health Services (NYSE:UHS – Get Free Report)‘s stock had its “equal weight” rating reiterated by stock analysts at Barclays in a report issued on Wednesday,Benzinga reports. They presently have a $179.00 target price on the health services provider’s stock. Barclays‘s target price suggests a potential upside of 10.80% from the stock’s previous close. Several […]